We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
When a long shot is worth a shot.
- Authors
Jacobs, Tom; Fischer, Jeff
- Abstract
The article focuses on a Northfield, Illinois- based biotechnology company Northfield Laboratories Inc. After 16 years in business, Northfield leads the race to develop a safe and effective alternative to transfused blood. The company's flagship product, PolyHeme, a human hemoglobin modified by pyridoxylation and glutaraldehyde polymerization, has several advantages over its natural counterpart. Northfield's positives include a huge market with no competition on the horizon and a debt-free company with low overhead, but the negatives are that this is a one-shot deal, and approval is simply more likely than not.
- Subjects
ILLINOIS; NORTHFIELD Laboratories Inc.; HEMOGLOBIN polymorphisms; BLOOD proteins; BIOTECHNOLOGY industries; GENETIC polymorphisms
- Publication
Nature Biotechnology, 2005, Vol 23, Issue 7, p805
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0705-805